🔎 Trials Near Me

홈 › 혈액암 › 텍사스 › Houston

TX Houston의 혈액암 임상 시험

혈액암 관련 연구 46개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

피험자 모집 중1상
  • MD Anderson Cancer Center - University of Texas, Houston
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07572006

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

피험자 모집 중3상
  • Quetzal Site 6, Houston
18세 ~ 71세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07504458

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

피험자 모집 중초기 1상
  • M D Anderson Cancer Center, Houston
12세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT04744116

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

피험자 모집 중1상
  • UT MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03816345

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

피험자 모집 중3상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07648264

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

피험자 모집 중관찰 연구
  • UT MD Anderson Cancer Center, Houston
전 연령 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07743476

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

피험자 모집 중3상
  • University of Texas MD Anderson Cancer Center ( Site 0007), Houston
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT03486873

Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

피험자 모집 중1상
  • Texas Children's Hospital, Houston
  • The Methodist Hospital, Houston
75세 이하 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT06345027

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

피험자 모집 중1상
  • Md Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07195916

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

피험자 모집 중2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04996875

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

피험자 모집 중
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT02464696

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

피험자 모집 중2상건강한 지원자 환영
  • M D Anderson Cancer Center, Houston
전 연령 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT04984551

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

피험자 모집 중1상
  • M D Anderson Cancer Center, Houston
전 연령 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT03425526

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

피험자 모집 중1/2상
  • MD Anderson, Houston
12세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT04588922

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

피험자 모집 중관찰 연구건강한 지원자 환영
  • UT MD Anderson Cancer Center, Houston
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

피험자 모집 중관찰 연구
  • M D Anderson Cancer Center, Houston
전 연령 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT01772771

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

피험자 모집 중1/2상
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05110742

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

피험자 모집 중3상
  • University of Texas, Houston
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07007312

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

피험자 모집 중초기 1상
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06184321

Expressive Writing for the Management of Stress in Cancer Survivors

피험자 모집 중
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT04776941

The Impact of COVID-19 on Pulmonary Procedures

피험자 모집 중관찰 연구건강한 지원자 환영
  • M D Anderson Cancer Center, Houston
전 연령 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT05022446

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06823167

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

피험자 모집 중관찰 연구
  • M D Anderson Cancer Center, Houston
전 연령 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT05108519

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

피험자 모집 중2상
  • University of Texas MD Anderson MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT06665100

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

피험자 모집 중1상
  • The University of TX MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07424833

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

피험자 모집 중2상
  • M D Anderson Cancer Center, Houston
12세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT04712539

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

피험자 모집 중관찰 연구
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545

Improving Comprehensive Care of Cancer Patients

피험자 모집 중건강한 지원자 환영
  • Baylor College of Medicine, Houston
18세 이상 · 모든 성별 · 2026. 6. 30. 업데이트됨 · NCT05323409

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT02074839

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

피험자 모집 중관찰 연구
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 12. 업데이트됨 · NCT00991094

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

피험자 모집 중관찰 연구
  • Texas Children's Hospital, Houston
0세 ~ 38세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT06131801

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

피험자 모집 중관찰 연구
  • M D Anderson Cancer Center, Houston
18세 ~ 39세 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT04551378

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

피험자 모집 중관찰 연구건강한 지원자 환영
  • M D Anderson Cancer Center, Houston
21세 이상 · 모든 성별 · 2026. 5. 26. 업데이트됨 · NCT05054413

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

피험자 모집 중관찰 연구
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 5. 20. 업데이트됨 · NCT05011045

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
13세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT04771572

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

피험자 모집 중3상
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
2세 ~ 18세 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT05711667

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

피험자 모집 중2상
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT05529069

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

피험자 모집 중
  • M D Anderson Cancer Center, Houston
6세 ~ 29세 · 모든 성별 · 2026. 5. 4. 업데이트됨 · NCT04678427

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

피험자 모집 중2상
  • The University of Texas M. D. Anderson Cancer Center, Houston
60세 이하 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT06807606

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT03328078

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

피험자 모집 중관찰 연구
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT04888338

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT05735184

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

피험자 모집 중1/2상
  • University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 6. 3. 업데이트됨 · NCT06119685

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

피험자 모집 중1상
  • Texas Children's Hospital/Baylor College of Medicine, Houston
1세 ~ 21세 · 모든 성별 · 2024. 12. 6. 업데이트됨 · NCT05476770

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2024. 11. 15. 업데이트됨 · NCT06034275

다른 도시의 혈액암 시험

Houston의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.